Immunitybio Inc · IBRX.US · Annual · 2025-12-31 · compared with 2024-12-31

Balance scale

Assets on one bar, liabilities stacked with equity on the other. Both use the same scale.

Assets $501.90M − (Liabilities $1.00B + Equity -$499.57M) = $0.00 · in balance

Composition

Named lines under 3% of the side are folded into Other. Each stack equals its reported total.

High-level mix

At most five slices. Assets use blue. Liabilities use orange and slate. Equity is green.

Change from prior period

Each step is the change in that group. The last bar is the selected period total.

Recent periods

Last eight periods. Cash, receivables, inventory, and PPE are assets. Total debt is orange. Equity is green.

Line detail

Percents use the same slices as the composition charts. The bar shows magnitude within the side.

Side
Group
Amount
% of side
Change
Change %
Assets
Cash
$88.33M
17.6%
-$55.09M
-38.4%
Assets
Receivables
$42.62M
8.5%
$39.96M
1,506.4%
Assets
Other current assets
$28.53M
5.7%
$4.68M
19.6%
Assets
PPE
$147.55M
29.4%
-$22.91M
-13.4%
Assets
Other
$194.87M
38.8%
$152.33M
358.1%
Liabilities + Equity
Long-term debt
$477.09M
95.1%
$15.22M
3.3%
Liabilities + Equity
Other liabilities
$524.38M
104.5%
$115.19M
28.2%
Liabilities + Equity
Equity
-$499.57M
-99.5%
-$10.48M
-2.1%